NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to fight fatty liver and diabetes together
Disease control Not yet recruitingThis study is testing whether a new drug called CS0159, when combined with the diabetes drug semaglutide, can help people with fatty liver disease, obesity, and type 2 diabetes. About 30 adults will take the combination or a placebo for 12 weeks. The main goals are to see if it h…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 17, 2026 02:21 UTC
-
Could a diabetes pill help teens with fatty liver? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether a type 2 diabetes medicine (SGLT2 inhibitor) can safely reduce liver fat in adolescents aged 12-20 who have obesity and non-alcoholic fatty liver disease (NAFLD). About 40 participants will receive either the drug or a placebo for a set period. The main g…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
AI diet coach takes on fatty liver in major new trial
Disease control Not yet recruitingThis study tests whether an artificial intelligence (AI) program that gives personalized diet and exercise advice can help people with non-alcoholic fatty liver disease (NAFLD) reduce liver fat more than standard lifestyle recommendations. About 216 adults with NAFLD and overweig…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New fatty liver drug enters early human testing
Disease control Not yet recruitingThis early-phase study tests a new drug called XTYW007 in 94 healthy volunteers and people with high LDL cholesterol. The main goal is to check safety and how the drug moves through the body, with a first look at its effect on blood fats. It is not yet recruiting and aims to gath…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New computer tool aims to stop missed fatty liver diagnoses in ERs
Diagnosis Not yet recruitingThis study tests a computer program that helps emergency room doctors notice fatty liver disease on scans, tell patients about it, and suggest next steps. About 4,700 adults who have fatty liver found by accident on an ER scan will take part. The goal is to make sure these findin…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated May 13, 2026 16:02 UTC
-
Scientists probe Insulin's role in liver fat and sugar
Knowledge-focused Not yet recruitingThis study looks at how changing insulin levels affects the liver's production of sugar and fat in people with insulin resistance, prediabetes, and fatty liver disease. Participants will undergo two procedures where insulin is either kept at a high level or lowered by half, and r…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC